10-Q Filing

BIO GREEN MED SOLUTION, INC. CIK: 1130166 Q1 2013

Filing Information

Form Type	10-Q
Accession Number	`0001104659-13-040858`
Period End Date	20130331
Filing Date	20130513
Fiscal Year	2013
Fiscal Period	Q1
XBRL Instance	cycc-20130331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 73 Cash Flow Statement 96 Comprehensive Income 3

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$16.41M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	420,682.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$23.64M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1.21M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$14.14M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1.21M	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	420,682.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.60M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$2.06M	USD	Point-in-time
Preferred stock, liquidation preference value (in dollars)	`PreferredStockLiquidationPreferenceValue`	$14.44B	USD	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$861.00K	USD	Point-in-time
Preferred stock, liquidation preference value (in dollars)	`PreferredStockLiquidationPreferenceValue`	$5.01B	USD	Point-in-time
Current assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$835.00K	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$18.87M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$17.03M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Property, plant and equipment (net)	`PropertyPlantAndEquipmentNet`	$129.00K	USD	Point-in-time
Property, plant and equipment (net)	`PropertyPlantAndEquipmentNet`	$184.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	8.69M	shares	Point-in-time
Long-term assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$353.00K	USD	Point-in-time
Long-term assets of discontinued operations	`AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$272.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	10.88M	shares	Point-in-time
Total assets	`Assets`	$17.49M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.69M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	10.88M	shares	Point-in-time
Total assets	`Assets`	$19.35M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.26M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.83M	USD	Point-in-time
Accrued and other current liabilities	`AccruedLiabilitiesCurrent`	$5.60M	USD	Point-in-time
Accrued and other current liabilities	`AccruedLiabilitiesCurrent`	$3.53M	USD	Point-in-time
Economic Rights measured at fair value	`WarrantsAndRightsOutstanding`	$550.00K	USD	Point-in-time
Economic Rights measured at fair value	`WarrantsAndRightsOutstanding`	$1.12M	USD	Point-in-time
Other liabilities measured at fair value	`OtherLiabilitiesCurrent`	$20.00K	USD	Point-in-time
Other liabilities measured at fair value	`OtherLiabilitiesCurrent`	$20.00K	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$323.00K	USD	Point-in-time
Current liabilities of discontinued operations	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$335.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.34M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.25M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.34M	USD	Point-in-time
Total liabilities	`Liabilities`	$7.25M	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2012 and March 31, 2013; 1,213,142 and 420,682 shares issued and outstanding at December 31, 2012 and March 31, 2013, respectively. Aggregate preference in liquidation of $14,436,390 and $5,006,116 at December 31, 2012 and March 31, 2013, respectively	`PreferredStockValue`	$1.00K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2012 and March 31, 2013; 8,686,484 and 10,881,780 shares issued and outstanding at December 31, 2012 and March 31, 2013, respectively	`CommonStockValue`	$9.00K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2012 and March 31, 2013; 8,686,484 and 10,881,780 shares issued and outstanding at December 31, 2012 and March 31, 2013, respectively	`CommonStockValue`	$11.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$292.11M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$280.21M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-193.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$48.00K	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-281.70M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-270.25M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.23M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$10.02M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.35M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$17.49M	USD	Point-in-time

Income Statement 73 line items

Line Item	Tag	Value	Unit	Period
(Loss) income from discontinued operations, tax	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	$10.00K	USD	1 Quarter
(Loss) income from discontinued operations, tax	`DiscontinuedOperationTaxEffectOfDiscontinuedOperation`	-	USD	1 Quarter
Collaboration and research and development revenue	`LicenseAndServicesRevenue`	$3.10M	USD	67 Qtrs
Grant revenue	`RevenueFromGrants`	$3.93M	USD	67 Qtrs
Grant revenue	`RevenueFromGrants`	$212.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$212.00K	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$7.03M	USD	67 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.35M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$193.97M	USD	67 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.58M	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$92.09M	USD	67 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$2.68M	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$1.77M	USD	1 Quarter
Goodwill and intangibles impairment	`GoodwillAndIntangibleAssetImpairmentNetDiscontinuedOperations`	$2.75M	USD	67 Qtrs
Other restructuring costs	`OtherRestructuringCosts`	$2.63M	USD	67 Qtrs
Total operating expenses	`CostsAndExpenses`	$3.12M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$291.45M	USD	67 Qtrs
Total operating expenses	`CostsAndExpenses`	$4.26M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.12M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-284.42M	USD	67 Qtrs
Operating loss	`OperatingIncomeLoss`	$-4.05M	USD	1 Quarter
Costs associated with aborted 2004 IPO	`PaymentsOfFinancingCosts`	$-3.55M	USD	67 Qtrs
Payment under guarantee	`PaymentUnderGuarantee`	$1.65M	USD	67 Qtrs
Non-cash consideration associated with stock purchase agreement	`ExpenseRelatedToStockPurchaseAgreement`	$423.00K	USD	67 Qtrs
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-570.00K	USD	1 Quarter
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$56.00K	USD	1 Quarter
Change in valuation of Economic Rights	`ChangeInValuationOfEconomicRights`	$-547.00K	USD	67 Qtrs
Change in valuation of liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$6.38M	USD	67 Qtrs
Change in valuation of liabilities measured at fair value	`GainLossOnDerivativeInstrumentsNetPretax`	$42.00K	USD	1 Quarter
Foreign exchange losses	`ForeignCurrencyTransactionGainLossBeforeTax`	$114.00K	USD	1 Quarter
Foreign exchange losses	`ForeignCurrencyTransactionGainLossBeforeTax`	$120.00K	USD	1 Quarter
Foreign exchange losses	`ForeignCurrencyTransactionGainLossBeforeTax`	$-3.88M	USD	67 Qtrs
Interest income	`InvestmentIncomeInterest`	$1.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$13.75M	USD	67 Qtrs
Interest income	`InvestmentIncomeInterest`	$6.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$4.57M	USD	67 Qtrs
Other income (expense)	`OtherNonoperatingIncome`	$47.00K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncome`	$81.00K	USD	67 Qtrs
Other income (expense)	`OtherNonoperatingIncome`	$4.00K	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$695.00K	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$153.00K	USD	1 Quarter
Total other (expense) income, net	`NonoperatingIncomeExpense`	$6.68M	USD	67 Qtrs
Loss from continuing operations before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-277.74M	USD	67 Qtrs
Loss from continuing operations before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.96M	USD	1 Quarter
Loss from continuing operations before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.36M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-20.05M	USD	67 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-168.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-258.00K	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-257.69M	USD	67 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-2.79M	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-3.10M	USD	1 Quarter
(Loss) income from discontinued operations, net of tax of $0 and $10 for the three months ended March 31, 2012 and 2013, respectively	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$16.00K	USD	1 Quarter
(Loss) income from discontinued operations, net of tax of $0 and $10 for the three months ended March 31, 2012 and 2013, respectively	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-12.13M	USD	67 Qtrs
(Loss) income from discontinued operations, net of tax of $0 and $10 for the three months ended March 31, 2012 and 2013, respectively	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-161.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-269.82M	USD	67 Qtrs
Net loss	`NetIncomeLoss`	$-3.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.96M	USD	1 Quarter
Dividend on preferred ordinary shares	`DividendsOnPreferredOrdinaryShares`	$38.12M	USD	67 Qtrs
Deemed dividend on convertible exchangeable preferred shares	`RedeemablePreferredStocksDividends`	$11.88M	USD	67 Qtrs
Deemed dividend on convertible exchangeable preferred shares	`RedeemablePreferredStocksDividends`	$8.37M	USD	1 Quarter
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$182.00K	USD	1 Quarter
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$4.51M	USD	67 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$122.00K	USD	1 Quarter
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-324.33M	USD	67 Qtrs
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.14M	USD	1 Quarter
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-11.57M	USD	1 Quarter
Net loss per share, continuing operations - basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-1.18	USD	1 Quarter
Net loss per share, continuing operations - basic and diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.38	USD	1 Quarter
Net loss per share, discontinued operations - basic and diluted (in dollars per share)	`IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare`	$-0.02	USD	1 Quarter
Net loss per share - basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.40	USD	1 Quarter
Net loss per share - basic and diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-1.18	USD	1 Quarter
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	7.82M	shares	1 Quarter
Weighted average common shares outstanding (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	9.79M	shares	1 Quarter

Cash Flow Statement 96 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-269.82M	USD	67 Qtrs
Net loss	`NetIncomeLoss`	$-3.08M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.96M	USD	1 Quarter
Accretion of interest on notes payable, net of amortization of debt premium	`AccretionExpense`	$100.00K	USD	67 Qtrs
Amortization of investment premiums, net	`InvestmentIncomeAmortizationOfPremium`	$-2.30M	USD	67 Qtrs
Change in valuation of liabilities measured at fair value	`ChangeInValuationOfLiabilitiesMeasuredAtFairValue`	$570.00K	USD	1 Quarter
Change in valuation of liabilities measured at fair value	`ChangeInValuationOfLiabilitiesMeasuredAtFairValue`	$6.92M	USD	67 Qtrs
Change in valuation of liabilities measured at fair value	`ChangeInValuationOfLiabilitiesMeasuredAtFairValue`	$-14.00K	USD	1 Quarter
Non-cash consideration associated with stock purchase agreement	`ExpenseRelatedToStockPurchaseAgreement`	$423.00K	USD	67 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$12.64M	USD	67 Qtrs
Depreciation	`DepreciationDepletionAndAmortization`	$15.00K	USD	1 Quarter
Depreciation	`DepreciationDepletionAndAmortization`	$26.00K	USD	1 Quarter
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$886.00K	USD	67 Qtrs
Fixed asset impairment	`ImpairmentOfLongLivedAssetsHeldForUse`	$221.00K	USD	67 Qtrs
Unrealized foreign exchange (gains) losses	`ForeignCurrencyTransactionGainLossUnrealized`	$-7.75M	USD	67 Qtrs
Deferred revenue	`RecognitionOfDeferredRevenue`	$98.00K	USD	67 Qtrs
Compensation for warrants issued to non-employees	`StockOptionPlanExpenses`	$1.22M	USD	67 Qtrs
Shares issued for IP rights	`IssuanceOfStocksAndWarrantsForServicesOrClaims`	$446.00K	USD	67 Qtrs
Loss (gain) on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$47.00K	USD	1 Quarter
Loss (gain) on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-38.00K	USD	67 Qtrs
Goodwill and intangibles impairment	`GoodwillAndIntangibleAssetImpairment`	$7.93M	USD	67 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$102.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$19.48M	USD	67 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$72.00K	USD	1 Quarter
Provision for restructuring	`PaymentsForRestructuring`	$-1.78M	USD	67 Qtrs
Amortization of issuance costs of Preferred Ordinary 'C' shares	`AmortizationOfFinancingCostsAndDiscounts`	$2.52M	USD	67 Qtrs
Transaction costs on sale of Economic Rights	`TransactionCostsOnSaleOfEconomicRights`	$33.00K	USD	67 Qtrs
Transaction costs on sale of Economic Rights	`TransactionCostsOnSaleOfEconomicRights`	$33.00K	USD	1 Quarter
Gain on termination of distribution agreements	`DisposalGroupIncludingDiscontinuedOperationGainLossOnTerminationOfDistributionAgreement`	$1.19M	USD	67 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$126.00K	USD	1 Quarter
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$779.00K	USD	67 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$482.00K	USD	1 Quarter
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-1.33M	USD	1 Quarter
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-807.00K	USD	1 Quarter
Accounts payable and other current liabilities	`IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities`	$-4.88M	USD	67 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.77M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-230.53M	USD	67 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-5.37M	USD	1 Quarter
Purchase of ALIGN	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.76M	USD	67 Qtrs
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$92.00K	USD	1 Quarter
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.00K	USD	1 Quarter
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.94M	USD	67 Qtrs
Minimum royalty payments received from termination of ALIGN license agreement	`PaymentsForProceedsFromOtherInvestingActivities`	$-132.00K	USD	1 Quarter
Minimum royalty payments received from termination of ALIGN license agreement	`PaymentsForProceedsFromOtherInvestingActivities`	$-132.00K	USD	67 Qtrs
Proceeds from sale of property, plant and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$24.00K	USD	1 Quarter
Proceeds from sale of property, plant and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$225.00K	USD	67 Qtrs
Purchase of short-term investments on deposit, net of maturities	`PaymentsToAcquireShortTermInvestments`	$156.66M	USD	67 Qtrs
Cash proceeds from redemption of short term securities	`ProceedsFromSaleOfShortTermInvestments`	$162.73M	USD	67 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-6.28M	USD	67 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$40.00K	USD	1 Quarter
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$15.00K	USD	1 Quarter
Payments of capital lease obligations	`RepaymentsOfLongTermCapitalLeaseObligations`	$3.72M	USD	67 Qtrs
Proceeds from issuance of ordinary and preferred ordinary shares, net of issuance costs	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$121.68M	USD	67 Qtrs
Proceeds from issuance of common stock and warrants, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$2.91M	USD	1 Quarter
Proceeds from issuance of common stock and warrants, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$3.41M	USD	1 Quarter
Proceeds from issuance of common stock and warrants, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$98.97M	USD	67 Qtrs
Proceeds from the exercise of stock options and warrants, net of issuance costs	`ProceedsFromStockOptionsExercised`	$34.00K	USD	1 Quarter
Proceeds from the exercise of stock options and warrants, net of issuance costs	`ProceedsFromStockOptionsExercised`	$267.00K	USD	67 Qtrs
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$2.03M	USD	67 Qtrs
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$129.00K	USD	1 Quarter
Repayment of government loan	`RepaymentsOfNotesPayable`	$455.00K	USD	67 Qtrs
Government loan received	`ProceedsFromNotesPayable`	$414.00K	USD	67 Qtrs
Loan received from Cyclacel Group plc	`ProceedsFromLoans`	$9.10M	USD	67 Qtrs
Proceeds of committable loan notes issued from shareholders	`ProceedsOfCommittableLoanNotesIssuedFromShareholders`	$8.88M	USD	67 Qtrs
Loans received from shareholders	`LoansAndLeasesReceivableRelatedPartiesCollections`	$-1.65M	USD	67 Qtrs
Cash and cash equivalents assumed on stock purchase of Xcyte	`CashAcquiredFromAcquisition`	$17.91M	USD	67 Qtrs
Costs associated with stock purchase	`PaymentsForRepurchaseOfEquity`	$1.95M	USD	67 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$2.94M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$250.72M	USD	67 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$3.29M	USD	1 Quarter
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-230.00K	USD	1 Quarter
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$225.00K	USD	67 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$2.00K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-809.00K	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$-2.27M	USD	1 Quarter
Net increase (decrease) in cash and cash equivalents	`NetCashProvidedByUsedInContinuingOperations`	$14.14M	USD	67 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$16.41M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$23.64M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$14.14M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$16.41M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$24.45M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$23.64M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$14.14M	USD	Point-in-time
Interest	`ProceedsFromInterestReceived`	$11.76M	USD	67 Qtrs
Interest	`ProceedsFromInterestReceived`	$1.00K	USD	1 Quarter
Interest	`ProceedsFromInterestReceived`	$5.00K	USD	1 Quarter
Taxes	`ProceedsFromIncomeTaxRefunds`	$18.77M	USD	67 Qtrs
Interest	`InterestPaidNet`	$-1.91M	USD	67 Qtrs
Acquisitions of equipment purchased through capital leases	`AcquisitionsOfEquipmentPurchasedThroughCapitalLeases`	$3.47M	USD	67 Qtrs
Issuance of common shares in connection with license agreements	`IssuanceOfOrdinarySharesInConnectionWithLicenseAgreements`	$592.00K	USD	67 Qtrs
Issuance of Ordinary shares on conversion of bridging loan	`IssuanceOfOrdinarySharesOnConversionOfBridgingLoan`	$1.64M	USD	67 Qtrs
Issuance of Preferred Ordinary 'C' shares on conversion of secured convertible loan notes and accrued interest	`IssuanceOfPreferredOrdinaryClassCSharesOnConversionOfSecuredConvertibleLoanNotesAndAccruedInterest`	$8.89M	USD	67 Qtrs
Issuance of Ordinary shares in lieu of cash bonus	`IssuanceOfOrdinarySharesInLieuOfCashBonus`	$181.00K	USD	1 Quarter
Issuance of Ordinary shares in lieu of cash bonus	`IssuanceOfOrdinarySharesInLieuOfCashBonus`	$345.00K	USD	67 Qtrs
Issuance of other long term payable on ALIGN acquisition	`NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1`	$1.12M	USD	67 Qtrs

Comprehensive Income 3 line items

Line Item	Tag	Value	Unit	Period
Comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-3.32M	USD	1 Quarter
Comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-2.95M	USD	1 Quarter
Comprehensive loss	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-270.01M	USD	67 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.